Revefenacin

Overview

Revefenacin is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL3833319).

API suppliers (7)

Suppliers of Revefenacin evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

• INKE SASpain1 active DMF
• Cipla USA, Inc.USA1 active DMF
• MSN Laboratories Private LimitedIndia1 active DMF GMP on record
• Mankind Pharma LimitedIndia1 active DMF GMP on record
• MEDICHEM MANUFACTURING (MALTA) LTDMalta1 active DMF GMP on record
• APITORIA PHARMA PRIVATE LTDIndia1 active DMF GMP on record
• SHANDONG RISEN-SUN PHARMACEUTICAL CO LTD1 active DMF

Patent & exclusivity (US)

Per the FDA Orange Book (1 approved US product), the latest listed US patent on Revefenacin expires 23 Oct 2039. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name

[1-[2-[[4-[(4-carbamoylpiperidin-1-yl)methyl]benzoyl]-methylamino]ethyl]piperidin-4-yl] N-(2-phenylphenyl)carbamate

Canonical SMILES

CN(CCN1CCC(CC1)OC(=O)NC2=CC=CC=C2C3=CC=CC=C3)C(=O)C4=CC=C(C=C4)CN5CCC(CC5)C(=O)N

InChIKey

FYDWDCIFZSGNBU-UHFFFAOYSA-N